✦ LIBER ✦

94 Treatment of Secondary Infliximab Failure in Crohn's Disease Based on Serum Levels of Infliximab and Antibodies Against Infliximab: The Danish Study of Optimizing Infliximab Therapy in Crohn's Disease (Do It Crohn) Randomized Clinical Trial

✍ Scribed by Steenholdt, Casper; Brynskov, Jorn; Thomsen, Ole.; Munck, Lars K.; Fallingborg, Jan; Christensen, Lisbet A.; Pedersen, Gitte; Kjeldsen, Jens; Jacobsen, Bent A.; Oxholm, Anne Sophie; Kjellberg, Jakob; Bendtzen, Klaus; Ainsworth, Mark A.

Book ID: 122331918
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 209 KB
Volume: 144
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(13)60074-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sa1243 Clinical Implications of Measurin

Sa1243 Clinical Implications of Measuring Drug and Anti-Drug Antibodies by Different Assays When Optimizing Infliximab Treatment Failure in Crohn's Disease

✍ Steenholdt, Casper; Bendtzen, Klaus; Brynskov, Jorn; Thomsen, Ole.; Ainsworth, M 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 107 KB

P536 Clinical implications of measuring

P536 Clinical implications of measuring drug and anti-drug antibodies by different assays when optimizing infliximab treatment failure in Crohn's disease

✍ Steenholdt, C.; Bendtzen, K.; Brynskov, J.; Thomsen, O.Ø.; Ainsworth, M.A. 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 48 KB

Predictive model for the outcome of infl

Predictive model for the outcome of infliximab therapy in Crohn's disease based on apoptotic pharmacogenetic index and clinical predictors

✍ Tibor Hlavaty; Marc Ferrante; Liesbet Henckaerts; Marie Pierik; Paul Rutgeerts; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

## Background: Infliximab (ifx) is an effective therapy for refractory luminal and fistulizing crohn's disease (cd). predictors of response could improve selection of patients with a higher probability of favorable outcomes and could improve the safety profile. we aimed to develop a predictive mode

Clinical Implications of Measuring Drug

Clinical Implications of Measuring Drug and Anti-Drug Antibodies by Different Assays When Optimizing Infliximab Treatment Failure in Crohn's Disease: Post Hoc Analysis of a Randomized Controlled Trial

✍ Steenholdt, Casper; Bendtzen, Klaus; Brynskov, Jørn; Thomsen, Ole \[emptyv]; Ain 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 273 KB

Sa1882 The New Immunoassay for the Accur

Sa1882 The New Immunoassay for the Accurate Determination of Antibodies to Infliximab, and Relationship Between Its Serum Level and Inflammatory Values in Crohn's Disease

✍ Imaeda, Hirotsugu; Andoh, Akira; Ban, Hiromitsu; Bamba, Shigeki; Sasaki, Masaya; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Clinical and endosonographic effect of c

Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study

✍ R. L. West; C. J. van der Woude; B. E. Hansen; R. J. F. Felt-Bersma; A. J. P. va 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB